Tscan Therapeutics Inc (TCRX) is around the top of the Biotechnology industry according to InvestorsObserver. TCRX received an overall rating of 81, which means that it scores higher than 81 percent of all stocks. Tscan Therapeutics Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 15 out of the 148 industries.
TCRX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on TCRX!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 81 would rank higher than 81 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Tscan Therapeutics Inc Stock Today?
Tscan Therapeutics Inc (TCRX) stock is trading at $6.23 as of 1:41 PM on Tuesday, Feb 27, a drop of -$0.57, or -8.32% from the previous closing price of $6.79. The stock has traded between $6.15 and $6.79 so far today. Volume today is low. So far 101,079 shares have traded compared to average volume of 142,965 shares.
Click Here to get the full Stock Report for Tscan Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
